202 related articles for article (PubMed ID: 17907378)
1. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species.
Baba M; Okamoto M; Takeuchi H
Antimicrob Agents Chemother; 1999 Oct; 43(10):2350-5. PubMed ID: 10508005
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
Hamasaki T; Okamoto M; Baba M
Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
[TBL] [Abstract][Full Text] [Related]
5. 2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro.
Kira T; Hashimoto K; Baba M; Okamoto T; Shigeta S
Antiviral Res; 1996 Oct; 32(2):55-62. PubMed ID: 8891164
[TBL] [Abstract][Full Text] [Related]
6. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of HIV-1 gene expression and transcription.
Baba M
Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
[TBL] [Abstract][Full Text] [Related]
8. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
[TBL] [Abstract][Full Text] [Related]
9. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
[TBL] [Abstract][Full Text] [Related]
14. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
16. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
17. Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives.
Baba M; Okamoto M; Makino M; Kimura Y; Ikeuchi T; Sakaguchi T; Okamoto T
Antimicrob Agents Chemother; 1997 Jun; 41(6):1250-5. PubMed ID: 9174179
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
19. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
Okamoto M; Ono M; Baba M
AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]